01 1PROCOS SpA
01 1Methyl Aminolevulinate Hydrochloride
01 1Italy
METHYL AMINOLEVULINATE HYDROCHLORIDE
NDC Package Code : 46016-7940
Start Marketing Date : 2021-11-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
31
PharmaCompass offers a list of Delta-Aminolevulinic Acid Methyl Ester API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Delta-Aminolevulinic Acid Methyl Ester manufacturer or Delta-Aminolevulinic Acid Methyl Ester supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Delta-Aminolevulinic Acid Methyl Ester manufacturer or Delta-Aminolevulinic Acid Methyl Ester supplier.
PharmaCompass also assists you with knowing the Delta-Aminolevulinic Acid Methyl Ester API Price utilized in the formulation of products. Delta-Aminolevulinic Acid Methyl Ester API Price is not always fixed or binding as the Delta-Aminolevulinic Acid Methyl Ester Price is obtained through a variety of data sources. The Delta-Aminolevulinic Acid Methyl Ester Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Metvixia manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metvixia, including repackagers and relabelers. The FDA regulates Metvixia manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metvixia API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Metvixia supplier is an individual or a company that provides Metvixia active pharmaceutical ingredient (API) or Metvixia finished formulations upon request. The Metvixia suppliers may include Metvixia API manufacturers, exporters, distributors and traders.
click here to find a list of Metvixia suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metvixia as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metvixia API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metvixia as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metvixia and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metvixia NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metvixia suppliers with NDC on PharmaCompass.
